MBM PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MBM PHARMA
Largest movements
- Receivables within one year +€387,226
up €387,226 (+246.0%), from €157,401 to €544,627
of which Other amounts receivable: +€322,236
- Cash -€295,751
down €295,751 (-48.2%), from €614,088 to €318,337
mainly Receivables within one year (-€387,226) and Contributions, distributions and other (-€382,000)
- Other debts +€86,000
up €86,000 (+29.1%), from €296,000 to €382,000
- Profit (loss) carried forward -€27,125
down €27,125 (-17.4%), from €156,154 to €129,030
- Trade debts +€18,452
up €18,452 (+12.2%), from €150,843 to €169,295
- Tax, wage and social debts +€15,277
up €15,277 (+18.2%), from €83,835 to €99,113
of which Taxes: +€12,226
- Gross operating margin +€113,372
up €113,372 (+12.6%), from €900,313 to €1.0m
- Staff costs +€23,305
up €23,305 (+4.2%), from €556,647 to €579,952
- Taxes +€13,988
up €13,988 (+21.2%), from €65,912 to €79,900
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €779,643 | €872,248 | +€92,605 | +11.9% |
| Fixed assets | 21/28 | €27 | €27 | = | 0.0% |
| Financial fixed assets | 28 | €27 | €27 | = | 0.0% |
| Current assets | 29/58 | €779,616 | €872,221 | +€92,605 | +11.9% |
| Amounts receivable within one year | 40/41 | €157,401 | €544,627 | +€387,226 | +246.0% |
| Trade receivables | 40 | €136,218 | €201,208 | +€64,990 | +47.7% |
| Other amounts receivable | 41 | €21,183 | €343,419 | +€322,236 | +1521.2% |
| Cash at bank and in hand | 54/58 | €614,088 | €318,337 | -€295,751 | -48.2% |
| Deferred charges and accrued income | 490/1 | €8,127 | €9,257 | +€1,130 | +13.9% |
| Total equity and liabilities | 10/49 | €779,643 | €872,248 | +€92,605 | +11.9% |
| Equity | 10/15 | €248,965 | €221,840 | -€27,125 | -10.9% |
| Contributions | 10/11 | €90,951 | €90,951 | = | 0.0% |
| Reserves | 13 | €1,859 | €1,859 | = | 0.0% |
| Distributable reserves | 133 | €1,859 | €1,859 | = | 0.0% |
| Profit (loss) carried forward | 14 | €156,154 | €129,030 | -€27,125 | -17.4% |
| Amounts payable | 17/49 | €530,679 | €650,408 | +€119,729 | +22.6% |
| Amounts payable within one year | 42/48 | €530,679 | €650,408 | +€119,729 | +22.6% |
| Trade debts | 44 | €150,843 | €169,295 | +€18,452 | +12.2% |
| Suppliers | 440/4 | €150,843 | €169,295 | +€18,452 | +12.2% |
| Taxes, remuneration and social security | 45 | €83,835 | €99,113 | +€15,277 | +18.2% |
| Taxes | 450/3 | €12,617 | €24,842 | +€12,226 | +96.9% |
| Remuneration and social security | 454/9 | €71,219 | €74,270 | +€3,052 | +4.3% |
| Other amounts payable | 47/48 | €296,000 | €382,000 | +€86,000 | +29.1% |
| Non-recurring operating income | 76A | €17,002 | €9,502 | -€7,499 | -44.1% |
| Remuneration, social security and pensions | 62 | €556,647 | €579,952 | +€23,305 | +4.2% |
| Other operating charges | 640/8 | €6 | - | -€6 | |
| Gross operating margin | 9900 | €900,313 | €1,013,684 | +€113,372 | +12.6% |
| Operating profit (loss) | 9901 | €343,659 | €433,732 | +€90,073 | +26.2% |
| Financial income | 75/76B | €1,871 | €1,779 | -€92 | -4.9% |
| Recurring financial income | 75 | €1,871 | €1,779 | -€92 | -4.9% |
| Financial charges | 65/66B | €2,168 | €736 | -€1,432 | -66.1% |
| Recurring financial charges | 65 | €2,168 | €736 | -€1,432 | -66.1% |
| Profit (loss) for the period before taxes | 9903 | €343,363 | €434,775 | +€91,413 | +26.6% |
| Income taxes | 67/77 | €65,912 | €79,900 | +€13,988 | +21.2% |
| Profit (loss) for the period | 9904 | €277,451 | €354,875 | +€77,425 | +27.9% |
| Profit (loss) for the period to be appropriated | 9905 | €277,451 | €354,875 | +€77,425 | +27.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.